Our Provider Reference Sheet identifies which services are reviewed by UniCare, which are reviewed by AIM, and how much notice is required. The reference sheet also includes information about member copays, notification requirements for preapprovals, and selected procedures for pre-review.
Effective January 1, 2021, the Provider Reference Sheet was updated to remove preapproval requirements for ECT (Electroconvulsive Therapy) as well as psychological and neuropsychological testing. Review the list of Procedure Codes for ECT and Psychological and Neuropsychological Testing
For preapprovals you also need to submit:
- Standardized Prior Authorization Form
- Precertification worksheets (Upon navigating to the PDF Library, please filter by the “Precertification” category)
For more information, visit our preapproval requirements member page or refer to our member handbooks for plan benefits, conditions, limitations and exclusions.
How to Request Preapproval
Here is who to notify to request preapproval:
- UniCare reviews: UniCare Provider Services at 800-442-9300
- AIM reviews: Contact AIM directly through the AIM web application or call 866-766-0247
- Express Scripts: For review of certain non-oncology specialty drugs for non-Medicare members only, call 855-283-7679
UniCare's partnership with AIM lets our providers use AIM's web-based application for services reviewed by AIM. Providers can log into the AIM application and complete the intake. In many cases, the entire review and approval process can be done online. Providers who already use AIM's web application will not have to re-register for UniCare.
Express Scripts, the administrator for the prescription drug plan or UniCare's non-Medicare members, covers and dispenses self- or office-administered specialty drugs (non-oncology). In addition, some specialty drugs require review and dispensing by Express Scripts, for non-Medicare members only. The list of these specialty drugs is updated periodically and posted. Review the Express Scripts Specialty Drug List.
Expanded review is required for certain infused specialty drugs. If a non-Medicare member will be getting infusions of certain non-oncology specialty drugs in a hospital outpatient setting, an expanded review will be conducted to review both the drug for clinical appropriateness and the level of care/site of service. The lists of specialty drugs that require level of care review is included in the Provider Reference Sheet.